Correlation Between Fate Therapeutics and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Caribou Biosciences, you can compare the effects of market volatilities on Fate Therapeutics and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Caribou Biosciences.
Diversification Opportunities for Fate Therapeutics and Caribou Biosciences
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Fate and Caribou is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Caribou Biosciences
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Caribou Biosciences. In addition to that, Fate Therapeutics is 1.11 times more volatile than Caribou Biosciences. It trades about -0.03 of its total potential returns per unit of risk. Caribou Biosciences is currently generating about -0.02 per unit of volatility. If you would invest 697.00 in Caribou Biosciences on September 26, 2024 and sell it today you would lose (528.00) from holding Caribou Biosciences or give up 75.75% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Caribou Biosciences
Performance |
Timeline |
Fate Therapeutics |
Caribou Biosciences |
Fate Therapeutics and Caribou Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Caribou Biosciences
The main advantage of trading using opposite Fate Therapeutics and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |